97 related articles for article (PubMed ID: 2315924)
21. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
22. Effect of 5-azacytidine on metallothionein inducibility and sensitivity to lethality of cadmium in rat osteosarcoma (ROS 17/2.8) cells.
Thomas DJ; Angle CR; Swanson SA
Toxicology; 1990 Dec; 65(1-2):169-78. PubMed ID: 1703334
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3.
Nambi P; Wu HL; Lipshutz D; Prabhakar U
Mol Pharmacol; 1995 Feb; 47(2):266-71. PubMed ID: 7870034
[TBL] [Abstract][Full Text] [Related]
24. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood BD
Endocrinology; 1990 Aug; 127(2):588-94. PubMed ID: 2115429
[TBL] [Abstract][Full Text] [Related]
26. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J
J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879
[TBL] [Abstract][Full Text] [Related]
27. 1 alpha,25-dihydroxyvitamin D3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression.
Jenis LG; Lian JB; Stein GS; Baran DT
J Cell Biochem; 1993 Nov; 53(3):234-9. PubMed ID: 8263040
[TBL] [Abstract][Full Text] [Related]
28. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ
J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C does not mediate the inhibitory action of lead on vitamin D3-dependent production of osteocalcin in osteoblastic bone cells.
Guity P; McCabe MJ; Pitts DK; Santini RP; Pounds JG
Toxicol Appl Pharmacol; 2002 Jan; 178(2):109-16. PubMed ID: 11814331
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures.
Leboy PS; Beresford JN; Devlin C; Owen ME
J Cell Physiol; 1991 Mar; 146(3):370-8. PubMed ID: 2022691
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
Chen TL; Hauschka PV; Feldman D
Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
[TBL] [Abstract][Full Text] [Related]
32. 1 alpha,25-Dihydroxyvitamin D3 rapidly increases nuclear calcium levels in rat osteosarcoma cells.
Sorensen AM; Bowman D; Baran DT
J Cell Biochem; 1993 Jun; 52(2):237-42. PubMed ID: 8396151
[TBL] [Abstract][Full Text] [Related]
33. Osteotoxicity of cadmium and lead in HOS TE 85 and ROS 17/2.8 cells: relation to metallothionein induction and mitochondrial binding.
Angle CR; Thomas DJ; Swanson SA
Biometals; 1993; 6(3):179-84. PubMed ID: 8400764
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid and glucocorticoids enhance the effect of 1,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid protein synthesis by rat osteosarcoma cells.
Nishimoto SK; Salka C; Nimni ME
J Bone Miner Res; 1987 Dec; 2(6):571-7. PubMed ID: 3484302
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro.
Skjødt H; Gallagher JA; Beresford JN; Couch M; Poser JW; Russell RG
J Endocrinol; 1985 Jun; 105(3):391-6. PubMed ID: 3873510
[TBL] [Abstract][Full Text] [Related]
36. 1 alpha, 25-Dihydroxyvitamin D3 and analogues of vitamin D3 induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria.
Haneji T; Kurihara N; Ikeda K; Kumegawa M
J Biochem; 1983 Oct; 94(4):1127-32. PubMed ID: 6317662
[TBL] [Abstract][Full Text] [Related]
37. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of 1,25(OH)2 vitamin D3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts.
Broess M; Riva A; Gerstenfeld LC
J Cell Biochem; 1995 Mar; 57(3):440-51. PubMed ID: 7768979
[TBL] [Abstract][Full Text] [Related]
39. 17 beta-oestradiol enhances the stimulatory effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity in human osteosarcoma SaOS-2 cells in a differentiation-dependent manner.
Rao LG; Wylie JN; Kung Sutherland MS; Murray TM
J Endocrinol; 1996 Jan; 148(1):181-7. PubMed ID: 8568466
[TBL] [Abstract][Full Text] [Related]
40. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
Farach-Carson MC; Sergeev I; Norman AW
Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
